Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Legislation & Advocacy

ACR Advances Legislation to Increase Patients’ Access to Biologic Drugs to Treat Rheumatoid Arthritis and Other Conditions

Staff  |  March 1, 2013

The Patients’ Access to Treatments Act of 2013 would prevent insurance companies from tacking on an additional cost-sharing fee for the specialty medications

Five Quick Ways To Make a Difference in Rheumatology Through Advocacy

Staff  |  March 1, 2013

The ACR’s online advocacy page has position statements and work plans on issues affecting rheumatology, and offers ways to get involved

ACR/ARHP Annual Meeting 2012: Federal Act Aims to Make New Biologic Drugs Available to Rheumatology Patients at a Lower Cost

Thomas R. Collins  |  March 1, 2013

The Biologics Price Competition and Innovation Act of 2009 would spur the development of products intended to be biosimilar to approved therapies

ACR Leaders Converge on Capitol Hill

Staff  |  February 1, 2013

American College of Rheumatology (ACR) members to discuss legislation and regulatory issues facing rheumatologists at this year’s annual ACR Advocacy Leadership Conference in Washington, D.C.

What’s in Store for Rheumatology in the 113th Congress?

Staff  |  January 1, 2013

In addition to seeking improvements to the Affordable Care Act, the American College of Rheumatology (ACR) will promote other legislative healthcare priorities including physician payment reform, patient access to treatment, and funding for medical research

ACR/ARHP Annual Meeting 2012: Identify Compliance Risks to Avoid Violating Medicare Rules

Mary Beth Nierengarten  |  January 1, 2013

Rheumatologists should develop a plan to keep in step with federal regulations

Strategic Thinking to Advance Rheumatology in the New Year

Audrey B. Uknis, MD  |  December 1, 2012

One of the first efforts this coming year will be the development of the American College of Rheumatology’s (ACR’s) 2013-2016 strategic plan

No Easy Solution for Lack of Transparency in the Practice of Medicine

Simon M. Helfgott, MD  |  December 1, 2012

Several well-publicized episodes highlight the apparent lack of disclosure of conflicts of interest in medicine, but will disclosure laws fix the problem or add to the confusion?

Much at Stake for Rheumatology in Lame Duck Session of Congress

Staff  |  December 1, 2012

Massive mandatory spending cuts—including a near 30% cut to Medicare physician reimbursement—are scheduled to go into effect in January

President’s Perspective: Big Questions, Bent Forks, and New Names

James O'Dell, MD  |  November 1, 2012

The ACR year in review

  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 86
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences